In response to a request from the Food and Drug Administration (FDA), the Institute of Medicine will conduct a workshop that will explore issues related to Advancing Regulatory Science for Medical Countermeasure Development. More specifically, the workshop will:
1) Examine ways to advance regulatory science for developing and evaluating medical countermeasures (MCMs, which includes drugs, devices and biologic medical products) for chemical, biological, radiological/nuclear (CBRN), and emerging infectious disease threats; and
2) Identify scientific opportunities to improve, simplify, or speed MCM development and improve the predictability and success rate of candidate MCMs.
Subject matter experts will be invited to participate in the workshop to discuss and help explore innovative tools, technologies, and applied scientific knowledge-base from within academia and industry that could facilitate MCM development and manufacturing, as well as evaluation of safety, quality, and efficacy of MCMs and of novel candidate MCM technologies.
For more information and registration, visit the Official Event Website.
